Gamma Knife Radiosurgery in Patients with Crooke's Cell Adenoma.

Gamma Knife Radiosurgery in Patients with Crooke's Cell Adenoma.:

Related Articles

Gamma Knife Radiosurgery in Patients with Crooke's Cell Adenoma.

World Neurosurg. 2020 Apr 03;:

Authors: Snyder MH, Shabo L, Lopes MB, Xu Z, Schlesinger D, Sheehan JP

Abstract

BACKGROUND: Crooke cell adenoma (CCA), is a very rare subtype of pituitary neoplasm which is known to be clinically aggressive. They can secrete adrenocorticotropic hormone, or may be endocrinologically silent. We aim to evaluate the effect of Gamma Knife radiosurgery (GKRS) on endocrine remission and tumor control.

PATIENTS AND METHODS: A total of five patients (2M/3F, median age at GKRS, 55 years, and range from 21 to 65 years) with a pathology-confirmed CCA treated with GKRS at Gamma Knife Center of the University of Virginia constituted this study. The median time interval between TSR and GKRS was 5.8 months. The median margin dose was 25Gy (range, 18Gy to 25Gy). Median treated adenoma volume was 3.12cc. The median follow-up was 107 months (range, 44 to 122 months).

RESULTS: Tumor control was achieved in all patients. Three patients achieved endocrine remission at the last follow-up. The median time interval to cortisol normalization when off of anti-hormone secreting medication was 12 months (range, 6 to 24 months). Newly developed or worsening endocrinopathy occurred in 3 patients at the time interval of 6, 15, and 18 months, respectively. Cranial nerve (CN) III neuropathy developed in 1 patient. Two patients required bilateral adrenalectomy at 44 months and 50 months following GKRS, respectively.

CONCLUSION: GKRS appears to be a safe and reasonably effective treatment option for CCA. Larger numbers of patients from a multicenter study are needed to verify these findings.

PMID: 32251826 [PubMed - as supplied by publisher]